Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $66.58 in the prior trading day, Halozyme Therapeutics Inc (NASDAQ: HALO) closed at $50.23, down -24.56%. In other words, the price has decreased by -$24.56 from its previous closing price. On the day, 14.0 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HALO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.48. For the most recent quarter (mrq), Quick Ratio is recorded 7.30 and its Current Ratio is at 8.39. In the meantime, Its Debt-to-Equity ratio is 3.13 whereas as Long-Term Debt/Eq ratio is at 3.13.
On October 07, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also upped its target price recommendation from $58 to $62.
JP Morgan Downgraded its Overweight to Neutral on September 19, 2024, whereas the target price for the stock was revised from $52 to $57.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 28 ’25 when Henderson Jeffrey William sold 4,497 shares for $60.37 per share. The transaction valued at 271,467 led to the insider holds 28,611 shares of the business.
Henderson Jeffrey William sold 503 shares of HALO for $32,217 on Apr 01 ’25. The Director now owns 33,108 shares after completing the transaction at $64.05 per share. On Mar 03 ’25, another insider, Henderson Jeffrey William, who serves as the Director of the company, sold 5,000 shares for $58.69 each. As a result, the insider received 293,458 and left with 33,611 shares of the company.
Valuation Measures:
As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.33, and their Forward P/E ratio for the next fiscal year is 7.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.71 while its Price-to-Book (P/B) ratio in mrq is 12.83.
Stock Price History:
Over the past 52 weeks, HALO has reached a high of $70.50, while it has fallen to a 52-week low of $42.01. The 50-Day Moving Average of the stock is -18.21%, while the 200-Day Moving Average is calculated to be -11.05%.
Shares Statistics:
A total of 123.17M shares are outstanding, with a floating share count of 121.86M. Insiders hold about 1.10% of the company’s shares, while institutions hold 101.44% stake in the company.
